This article first appeared on GuruFocus .
Release Date: February 17, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Narayana Hrudayalaya Ltd ( BOM:539551 ) reported strong profit growth in its India business for the second consecutive quarter, driven by transformation programs and payer mix optimization.
-
The company has seen significant margin expansion in its India operations, with a 150 to 200 basis point increase year-over-year.
-
The Bangalore cluster experienced strong growth due to high-end robotic surgeries and increased domestic footfalls.
-
The oncology department is the fastest-growing segment and is expected to become a major revenue contributor alongside cardiac services.
-
Narayana Hrudayalaya Ltd ( BOM:539551 ) is focusing on expanding its insurance offerings and integrated care services, which have been well-received in the market.
Negative Points
-
The company is still facing challenges in achieving break-even for its insurance and clinics business segments.
-
The northern cluster in India experienced softer growth due to receivable issues and increased competition from new hospitals.
-
The UK operations are currently less profitable compared to India and Cayman, with efforts ongoing to improve margins.
-
There is increased competition in the Bangalore market, with new hospitals being established, which may impact short-term profitability.
-
The company faces challenges in the Gurgaon market due to competition from larger hospitals, affecting profitability and patient acquisition.
Q & A Highlights
-
Warning! GuruFocus has detected 1 Warning Sign with BOM:539551.
-
Is BOM:539551 fairly valued? Test your thesis with our free DCF calculator.
Q: The margin expansion in India has been significant over the last two quarters. Do you expect this trend to continue? A: R. Venkatesh, Group COO, explained that the transformation programs and payer mix optimization have led to higher revenue and better margins. While specific guidance wasn't provided, efforts will continue to maintain these margins barring any short-term impacts.
Q: When can we expect the insurance and clinics segment to break even? A: Ravi Vishwanath, CEO of Narayana One Health, stated that the focus is currently on attracting customers and building propositions. It's too early to predict a break-even timeline, but efforts are being made to minimize margin dilution.
Q: What has driven the strong growth in the Bangalore cluster this quarter? A: R. Venkatesh, Group COO, attributed the growth to higher realizations from high-end robotic work and payer mix optimization. The focus on domestic volumes and revenues has also contributed to improved margins and revenues.
Q: How does the company plan to address the competition in the Bangalore market? A: Viren Prasad Shetty, Executive Vice Chairman, acknowledged the enhanced competition but noted that Bangalore is a large market with room for growth. The company expects short-term impacts but believes long-term demand will support growth.
Q: What are the plans for the UK operations to improve margins? A: Vivek Agarwal, Senior Manager, mentioned implementing operational efficiencies and increasing the private market share as key strategies. The focus will be on scaling the technology platform and improving revenue from non-NHS sources.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
